Cargando...

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer, and such hyperactivation is generally associated with a poor clinical prognosis. In the tumour microenvironment, IL-6/JAK/STAT3 signalling acts to drive the proliferation, survival, invasiveness, and metastasis of tumou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nat Rev Clin Oncol
Autores principales: Johnson, Daniel E., O’Keefe, Rachel A., Grandis, Jennifer R.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5858971/
https://ncbi.nlm.nih.gov/pubmed/29405201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2018.8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!